Last updated
Vanguard Health Care Index Fund (VHT)
Price 253.89元
List of Constituents
VHT Constituents. Through this analysis, you can identify the individual stocks held by the ETF and further analyze their fair value and value range.
| Rank | Ticker | Name | Ratio |
|---|---|---|---|
| 1 | LLY | Eli Lilly & Co. | 10.52% |
| 2 | UNH | UnitedHealth Group Inc. | 9.22% |
| 3 | ABBV | AbbVie Inc. | 4.79% |
| 4 | JNJ | Johnson & Johnson | 4.6% |
| 5 | MRK | Merck & Co. Inc. | 4.03% |
| 6 | ABT | Abbott Laboratories | 3.38% |
| 7 | TMO | Thermo Fisher Scientific Inc. | 3.31% |
| 8 | ISRG | Intuitive Surgical Inc. | 3.15% |
| 9 | DHR | Danaher Corp. | 2.55% |
| 10 | AMGN | Amgen Inc. | 2.49% |
| 11 | PFE | Pfizer Inc. | 2.43% |
| 12 | SYK | Stryker Corp. | 2.2% |
| 13 | BSX | Boston Scientific Corp. | 2.19% |
| 14 | VRTX | Vertex Pharmaceuticals Inc. | 1.98% |
| 15 | BMY | Bristol-Myers Squibb Co. | 1.96% |
| 16 | GILD | Gilead Sciences Inc. | 1.89% |
| 17 | MDT | Medtronic plc | 1.82% |
| 18 | CI | Cigna Corp. | 1.55% |
| 19 | ANTM | Anthem Inc. | 1.54% |
| 20 | REGN | Regeneron Pharmaceuticals Inc. | 1.33% |
| 21 | MCK | McKesson Corp. | 1.33% |
| 22 | ZTS | Zoetis Inc. | 1.3% |
| 23 | CVS | CVS Health Corp. | 1.23% |
| 24 | BDX | Becton Dickinson and Co. | 1.05% |
| 25 | HCA | HCA Healthcare Inc. | 1.04% |
| 26 | ABC | AmerisourceBergen Corp. Class A | 0.73% |
| 27 | EW | Edwards Lifesciences Corp. | 0.7% |
| 28 | A | Agilent Technologies Inc. | 0.65% |
| 29 | GEHC | GE HealthCare Technologies Inc. | 0.62% |
| 30 | IQV | IQVIA Holdings Inc. | 0.6% |
| 31 | RMD | ResMed Inc. | 0.6% |
| 32 | HUM | Humana Inc. | 0.58% |
| 33 | IDXX | IDEXX Laboratories Inc. | 0.57% |
| 34 | VEEV | Veeva Systems Inc. Class A | 0.57% |
| 35 | ALNY | Alnylam Pharmaceuticals Inc. | 0.53% |
| 36 | CNC | Centene Corp. | 0.52% |
| 37 | DXCM | DexCom Inc. | 0.51% |
| 38 | CAH | Cardinal Health Inc. | 0.48% |
| 39 | MTD | Mettler-Toledo International Inc. | 0.44% |
| 40 | WST | West Pharmaceutical Services Inc. | 0.39% |
| 41 | BIIB | Biogen Inc. | 0.38% |
| 42 | ILMN | Illumina Inc. | 0.38% |
| 43 | ZBH | Zimmer Biomet Holdings Inc. | 0.37% |
| 44 | WAT | Waters Corp. | 0.37% |
| 45 | STE | STERIS plc | 0.35% |
| 46 | COO | Cooper Cos. Inc. | 0.34% |
| 47 | LH | Labcorp Holdings Inc. | 0.33% |
| 48 | NTRA | Natera Inc. | 0.32% |
| 49 | PODD | Insulet Corp. | 0.31% |
| 50 | HOLX | Hologic Inc. | 0.3% |
| 51 | DGX | Quest Diagnostics Inc. | 0.3% |
| 52 | MOH | Molina Healthcare Inc. | 0.29% |
| 53 | BAX | Baxter International Inc. | 0.28% |
| 54 | ALGN | Align Technology Inc. | 0.27% |
| 55 | VTRS | Viatris Inc. | 0.26% |
| 56 | UTHR | United Therapeutics Corp. | 0.26% |
| 57 | MRNA | Moderna Inc. | 0.23% |
| 58 | PKI | PerkinElmer Inc. | 0.23% |
| 59 | AVTR | Avantor Inc. | 0.22% |
| 60 | THC | Tenet Healthcare Corp. | 0.22% |
| 61 | BMRN | BioMarin Pharmaceutical Inc. | 0.21% |
| 62 | NBIX | Neurocrine Biosciences Inc. | 0.21% |
| 63 | INCY | Incyte Corp. | 0.2% |
| 64 | TECH | Bio-Techne Corp. | 0.2% |
| 65 | UHS | Universal Health Services Inc. Class B | 0.2% |
| 66 | INSM | Insmed Inc. | 0.2% |
| 67 | EXAS | Exact Sciences Corp. | 0.19% |
| 68 | CTLT | Catalent Inc. | 0.18% |
| 69 | RPRX | Royalty Pharma plc Class A | 0.17% |
| 70 | CRL | Charles River Laboratories International Inc. | 0.17% |
| 71 | EHC | Encompass Health Corp. | 0.17% |
| 72 | PCVX | Vaxcyte Inc. | 0.17% |
| 73 | SOLV | Solventum Corp. | 0.17% |
| 74 | HSIC | Henry Schein Inc. | 0.16% |
| 75 | TFX | Teleflex Inc. | 0.15% |
| 76 | PEN | Penumbra Inc. | 0.15% |
| 77 | MEDP | Medpace Holdings Inc. | 0.15% |
| 78 | EXEL | Exelixis Inc. | 0.15% |
| 79 | SRPT | Sarepta Therapeutics Inc. | 0.14% |
| 80 | HQY | HealthEquity Inc. | 0.14% |
| 81 | ENSG | Ensign Group Inc. | 0.14% |
| 82 | RGEN | Repligen Corp. | 0.13% |
| 83 | CHE | Chemed Corp. | 0.13% |
| 84 | MASI | Masimo Corp. | 0.13% |
| 85 | ITCI | Intra-Cellular Therapies Inc. | 0.13% |
| 86 | GKOS | Glaukos Corp. | 0.13% |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 0.12% |
| 88 | GMED | Globus Medical Inc. | 0.12% |
| 89 | DVA | DaVita Inc. | 0.12% |
| 90 | BIO | Bio-Rad Laboratories Inc. Class A | 0.11% |
| 91 | ELAN | Elanco Animal Health Inc. | 0.11% |
| 92 | RVMD | REVOLUTION Medicines Inc. | 0.11% |
| 93 | HALO | Halozyme Therapeutics Inc. | 0.1% |
| 94 | BRKR | Bruker Corp. | 0.1% |
| 95 | LNTH | Lantheus Holdings Inc. | 0.1% |
| 96 | MMSI | Merit Medical Systems Inc. | 0.1% |
| 97 | CYTK | Cytokinetics Inc. | 0.1% |
| 98 | BPMC | Blueprint Medicines Corp. | 0.1% |
| 99 | DOCS | Doximity Inc. Class A | 0.1% |
| 100 | INSP | Inspire Medical Systems Inc. | 0.09% |
| 101 | Corcept Therapeutics Inc. | 0.09% | |
| 102 | Hims & Hers Health Inc. | 0.09% | |
| 103 | Viking Therapeutics Inc. | 0.09% | |
| 104 | IONS | Ionis Pharmaceuticals Inc. | 0.08% |
| 105 | Integer Holdings Corp. | 0.08% | |
| 106 | RadNet Inc. | 0.08% | |
| 107 | TG Therapeutics Inc. | 0.08% | |
| 108 | Crinetics Pharmaceuticals Inc. | 0.08% | |
| 109 | PROCEPT BioRobotics Corp. | 0.08% | |
| 110 | ADMA Biologics Inc. | 0.08% | |
| 111 | ROIV | Roivant Sciences Ltd. | 0.08% |
| 112 | Organon & Co. | 0.07% | |
| 113 | Dentsply Sirona Inc. | 0.07% | |
| 114 | Option Care Health Inc. | 0.07% | |
| 115 | Haemonetics Corp. | 0.07% | |
| 116 | CRISPR Therapeutics AG | 0.07% | |
| 117 | Alkermes plc | 0.07% | |
| 118 | Prestige Consumer Healthcare Inc. | 0.07% | |
| 119 | Ultragenyx Pharmaceutical Inc. | 0.07% | |
| 120 | Krystal Biotech Inc. | 0.07% | |
| 121 | MDGL | Madrigal Pharmaceuticals Inc. | 0.07% |
| 122 | Guardant Health Inc. | 0.07% | |
| 123 | Acadia Healthcare Co. Inc. | 0.06% | |
| 124 | Perrigo Co. plc | 0.06% | |
| 125 | Envista Holdings Corp. | 0.06% | |
| 126 | ICU Medical Inc. | 0.06% | |
| 127 | CRVL | CorVel Corp. | 0.06% |
| 128 | Avidity Biosciences Inc. | 0.06% | |
| 129 | NUVL | Nuvalent Inc. Class A | 0.06% |
| 130 | Biohaven Ltd. | 0.06% | |
| 131 | Arrowhead Pharmaceuticals Inc. | 0.05% | |
| 132 | Amedisys Inc. | 0.05% | |
| 133 | Neogen Corp. | 0.05% | |
| 134 | LivaNova plc | 0.05% | |
| 135 | Denali Therapeutics Inc. | 0.05% | |
| 136 | PTC Therapeutics Inc. | 0.05% | |
| 137 | Twist Bioscience Corp. | 0.05% | |
| 138 | TransMedics Group Inc. | 0.05% | |
| 139 | Veracyte Inc. | 0.05% | |
| 140 | Agios Pharmaceuticals Inc. | 0.05% | |
| 141 | Axsome Therapeutics Inc. | 0.05% | |
| 142 | Vericel Corp. | 0.05% | |
| 143 | Bridgebio Pharma Inc. | 0.05% | |
| 144 | Rhythm Pharmaceuticals Inc. | 0.05% | |
| 145 | Arcellx Inc. | 0.05% | |
| 146 | Apellis Pharmaceuticals Inc. | 0.04% | |
| 147 | Premier Inc. Class A | 0.04% | |
| 148 | iRhythm Technologies Inc. | 0.04% | |
| 149 | Omnicell Inc. | 0.04% | |
| 150 | Inari Medical Inc. | 0.04% | |
| 151 | Select Medical Holdings Corp. | 0.04% | |
| 152 | Enovis Corp. | 0.04% | |
| 153 | CONMED Corp. | 0.04% | |
| 154 | Amicus Therapeutics Inc. | 0.04% | |
| 155 | Xenon Pharmaceuticals Inc. | 0.04% | |
| 156 | Addus HomeCare Corp. | 0.04% | |
| 157 | Ligand Pharmaceuticals Inc. | 0.04% | |
| 158 | NeoGenomics Inc. | 0.04% | |
| 159 | LeMaitre Vascular Inc. | 0.04% | |
| 160 | SpringWorks Therapeutics Inc. | 0.04% | |
| 161 | Merus NV | 0.04% | |
| 162 | Catalyst Pharmaceuticals Inc. | 0.04% | |
| 163 | QuidelOrtho Corp. | 0.04% | |
| 164 | UFP Technologies Inc. | 0.04% | |
| 165 | Geron Corp. | 0.04% | |
| 166 | Vera Therapeutics Inc. Class A | 0.04% | |
| 167 | Scholar Rock Holding Corp. | 0.04% | |
| 168 | SMMT | Summit Therapeutics Inc. | 0.04% |
| 169 | Novocure Ltd. | 0.03% | |
| 170 | Teladoc Health Inc. | 0.03% | |
| 171 | Integra LifeSciences Holdings Corp. | 0.03% | |
| 172 | Intellia Therapeutics Inc. | 0.03% | |
| 173 | Tandem Diabetes Care Inc. | 0.03% | |
| 174 | Brooks Automation Inc. | 0.03% | |
| 175 | Privia Health Group Inc. | 0.03% | |
| 176 | Beam Therapeutics Inc. | 0.03% | |
| 177 | 10X Genomics Inc. Class A | 0.03% | |
| 178 | Patterson Cos. Inc. | 0.03% | |
| 179 | ACADIA Pharmaceuticals Inc. | 0.03% | |
| 180 | AtriCure Inc. | 0.03% | |
| 181 | Supernus Pharmaceuticals Inc. | 0.03% | |
| 182 | Xencor Inc. | 0.03% | |
| 183 | Apollo Medical Holdings Inc. | 0.03% | |
| 184 | Celldex Therapeutics Inc. | 0.03% | |
| 185 | Amphastar Pharmaceuticals Inc. | 0.03% | |
| 186 | Iovance Biotherapeutics Inc. | 0.03% | |
| 187 | Surgery Partners Inc. | 0.03% | |
| 188 | Kymera Therapeutics Inc. | 0.03% | |
| 189 | National HealthCare Corp. | 0.03% | |
| 190 | MannKind Corp. | 0.03% | |
| 191 | Keros Therapeutics Inc. | 0.03% | |
| 192 | Sotera Health Co. | 0.03% | |
| 193 | Recursion Pharmaceuticals Inc. Class A | 0.03% | |
| 194 | Protagonist Therapeutics Inc. | 0.03% | |
| 195 | Akero Therapeutics Inc. | 0.03% | |
| 196 | RxSight Inc. | 0.03% | |
| 197 | Fortrea Holdings Inc. | 0.03% | |
| 198 | Ideaya Biosciences Inc. | 0.03% | |
| 199 | Mirum Pharmaceuticals Inc. | 0.03% | |
| 200 | Dynavax Technologies Corp. | 0.03% | |
| 201 | Dyne Therapeutics Inc. | 0.03% | |
| 202 | WaVe Life Sciences Ltd. | 0.03% | |
| 203 | Concentra Group Holdings Parent Inc. | 0.03% | |
| 204 | AMN Healthcare Services Inc. | 0.02% | |
| 205 | Progyny Inc. | 0.02% | |
| 206 | STAAR Surgical Co. | 0.02% | |
| 207 | BioCryst Pharmaceuticals Inc. | 0.02% | |
| 208 | Evolent Health Inc. Class A | 0.02% | |
| 209 | Arvinas Inc. | 0.02% | |
| 210 | Tilray Inc. | 0.02% | |
| 211 | Novavax Inc. | 0.02% | |
| 212 | Myriad Genetics Inc. | 0.02% | |
| 213 | Schrodinger Inc./United States | 0.02% | |
| 214 | Phreesia Inc. | 0.02% | |
| 215 | Certara Inc. | 0.02% | |
| 216 | Harmony Biosciences Holdings Inc. | 0.02% | |
| 217 | Travere Therapeutics Inc. | 0.02% | |
| 218 | US Physical Therapy Inc. | 0.02% | |
| 219 | Alignment Healthcare Inc. | 0.02% | |
| 220 | Syndax Pharmaceuticals Inc. | 0.02% | |
| 221 | CareDx Inc. | 0.02% | |
| 222 | Rocket Pharmaceuticals Inc. | 0.02% | |
| 223 | Aurinia Pharmaceuticals Inc. | 0.02% | |
| 224 | Innoviva Inc. | 0.02% | |
| 225 | Brookdale Senior Living Inc. | 0.02% | |
| 226 | BioLife Solutions Inc. | 0.02% | |
| 227 | Alphatec Holdings Inc. | 0.02% | |
| 228 | Collegium Pharmaceutical Inc. | 0.02% | |
| 229 | Viridian Therapeutics Inc. | 0.02% | |
| 230 | Clover Health Investments Corp. Class A | 0.02% | |
| 231 | CryoLife Inc. | 0.02% | |
| 232 | Immunovant Inc. | 0.02% | |
| 233 | Nurix Therapeutics Inc. | 0.02% | |
| 234 | Pennant Group Inc. | 0.02% | |
| 235 | MiMedx Group Inc. | 0.02% | |
| 236 | Amneal Pharmaceuticals Inc. | 0.02% | |
| 237 | Janux Therapeutics Inc. | 0.02% | |
| 238 | Embecta Corp. | 0.02% | |
| 239 | Tarsus Pharmaceuticals Inc. | 0.02% | |
| 240 | MEDNAX Inc. | 0.02% | |
| 241 | Disc Medicine Inc. | 0.02% | |
| 242 | Ardelyx Inc. | 0.02% | |
| 243 | ANI Pharmaceuticals Inc. | 0.02% | |
| 244 | MoonLake Immunotherapeutics Class A | 0.02% | |
| 245 | Harrow Inc. | 0.02% | |
| 246 | Apogee Therapeutics Inc. | 0.02% | |
| 247 | Arcutis Biotherapeutics Inc. | 0.02% | |
| 248 | Praxis Precision Medicines Inc. | 0.02% | |
| 249 | Edgewise Therapeutics Inc. | 0.02% | |
| 250 | Spyre Therapeutics Inc. | 0.02% | |
| 251 | Soleno Therapeutics Inc. | 0.02% | |
| 252 | WAY | Waystar Holding Corp. | 0.02% |
| 253 | BrightSpring Health Services Inc. | 0.02% | |
| 254 | Avadel Pharmaceuticals plc | 0.02% | |
| 255 | LifeStance Health Group Inc. | 0.02% | |
| 256 | GeneDx Holdings Corp. Class A | 0.02% | |
| 257 | agilon health Inc. | 0.01% | |
| 258 | Pacira BioSciences Inc. | 0.01% | |
| 259 | Prothena Corp. plc | 0.01% | |
| 260 | Maravai LifeSciences Holdings Inc. Class A | 0.01% | |
| 261 | Revance Therapeutics Inc. | 0.01% | |
| 262 | Pacific Biosciences of California Inc. | 0.01% | |
| 263 | Relay Therapeutics Inc. | 0.01% | |
| 264 | Vir Biotechnology Inc. | 0.01% | |
| 265 | AdaptHealth Corp. | 0.01% | |
| 266 | Ironwood Pharmaceuticals Inc. Class A | 0.01% | |
| 267 | CryoPort Inc. | 0.01% | |
| 268 | Cross Country Healthcare Inc. | 0.01% | |
| 269 | Owens & Minor Inc. | 0.01% | |
| 270 | Verve Therapeutics Inc. | 0.01% | |
| 271 | Arcus Biosciences Inc. | 0.01% | |
| 272 | Establishment Labs Holdings Inc. | 0.01% | |
| 273 | Avanos Medical Inc. | 0.01% | |
| 274 | Avid Bioservices Inc. | 0.01% | |
| 275 | Cytek Biosciences Inc. | 0.01% | |
| 276 | Anavex Life Sciences Corp. | 0.01% | |
| 277 | Emergent BioSolutions Inc. | 0.01% | |
| 278 | Allogene Therapeutics Inc. | 0.01% | |
| 279 | Varex Imaging Corp. | 0.01% | |
| 280 | Kura Oncology Inc. | 0.01% | |
| 281 | REGENXBIO Inc. | 0.01% | |
| 282 | OPKO Health Inc. | 0.01% | |
| 283 | DocGo Inc. | 0.01% | |
| 284 | uniQure NV | 0.01% | |
| 285 | Fulgent Genetics Inc. | 0.01% | |
| 286 | Adaptive Biotechnologies Corp. | 0.01% | |
| 287 | Mesa Laboratories Inc. | 0.01% | |
| 288 | Simulations Plus Inc. | 0.01% | |
| 289 | ImmunityBio Inc. | 0.01% | |
| 290 | Cerus Corp. | 0.01% | |
| 291 | Enhabit Inc. | 0.01% | |
| 292 | Accolade Inc. | 0.01% | |
| 293 | Cogent Biosciences Inc. | 0.01% | |
| 294 | OrthoPediatrics Corp. | 0.01% | |
| 295 | Vanda Pharmaceuticals Inc. | 0.01% | |
| 296 | HealthStream Inc. | 0.01% | |
| 297 | Theravance Biopharma Inc. | 0.01% | |
| 298 | Castle Biosciences Inc. | 0.01% | |
| 299 | SI-BONE Inc. | 0.01% | |
| 300 | Butterfly Network Inc. | 0.01% | |
| 301 | AngioDynamics Inc. | 0.01% | |
| 302 | Paragon 28 Inc. | 0.01% | |
| 303 | Sana Biotechnology Inc. | 0.01% | |
| 304 | AnaptysBio Inc. | 0.01% | |
| 305 | MaxCyte Inc. | 0.01% | |
| 306 | Replimune Group Inc. | 0.01% | |
| 307 | Surmodics Inc. | 0.01% | |
| 308 | Health Catalyst Inc. | 0.01% | |
| 309 | Arcturus Therapeutics Holdings Inc. | 0.01% | |
| 310 | SIGA Technologies Inc. | 0.01% | |
| 311 | Treace Medical Concepts Inc. | 0.01% | |
| 312 | Quanterix Corp. | 0.01% | |
| 313 | GoodRx Holdings Inc. Class A | 0.01% | |
| 314 | Ocugen Inc. | 0.01% | |
| 315 | Community Health Systems Inc. | 0.01% | |
| 316 | Orthofix Medical Inc. | 0.01% | |
| 317 | Phibro Animal Health Corp. Class A | 0.01% | |
| 318 | OraSure Technologies Inc. | 0.01% | |
| 319 | Nuvation Bio Inc. | 0.01% | |
| 320 | Erasca Inc. | 0.01% | |
| 321 | Stoke Therapeutics Inc. | 0.01% | |
| 322 | Humacyte Inc. | 0.01% | |
| 323 | MeiraGTx Holdings plc | 0.01% | |
| 324 | Phathom Pharmaceuticals Inc. | 0.01% | |
| 325 | Zimvie Inc. | 0.01% | |
| 326 | Monte Rosa Therapeutics Inc. | 0.01% | |
| 327 | Y-mAbs Therapeutics Inc. | 0.01% | |
| 328 | Pliant Therapeutics Inc. | 0.01% | |
| 329 | Altimmune Inc. | 0.01% | |
| 330 | Entrada Therapeutics Inc. | 0.01% | |
| 331 | OmniAb Inc. | 0.01% | |
| 332 | 89bio Inc. | 0.01% | |
| 333 | Day One Biopharmaceuticals Inc. | 0.01% | |
| 334 | Liquidia Technologies Inc. | 0.01% | |
| 335 | Terns Pharmaceuticals Inc. | 0.01% | |
| 336 | Evolus Inc. | 0.01% | |
| 337 | Enliven Therapeutics Inc. | 0.01% | |
| 338 | Fluidigm Corp. | 0.01% | |
| 339 | Cullinan Therapeutics Inc. | 0.01% | |
| 340 | Immunome Inc. | 0.01% | |
| 341 | Ocular Therapeutix Inc. | 0.01% | |
| 342 | EyePoint Pharmaceuticals Inc. | 0.01% | |
| 343 | Mind Medicine MindMed Inc. | 0.01% | |
| 344 | Zymeworks Inc. | 0.01% | |
| 345 | Astria Therapeutics Inc. | 0.01% | |
| 346 | Olema Pharmaceuticals Inc. | 0.01% | |
| 347 | ORIC Pharmaceuticals Inc. | 0.01% | |
| 348 | ARS Pharmaceuticals Inc. | 0.01% | |
| 349 | Savara Inc. | 0.01% | |
| 350 | Cargo Therapeutics Inc. | 0.01% | |
| 351 | GRAIL Inc. | 0.01% | |
| 352 | Kiniksa Pharmaceuticals International plc Class A | 0.01% | |
| 353 | PACS Group Inc. | 0.01% | |
| 354 | CG oncology Inc. | 0.01% | |
| 355 | Neumora Therapeutics Inc. | 0.01% | |
| 356 | Arbutus Biopharma Corp. | 0.01% | |
| 357 | ArriVent Biopharma Inc. | 0.01% | |
| 358 | Bioventus Inc. | 0.01% | |
| 359 | iRadimed Corp. | 0.01% | |
| 360 | Annexon Inc. | 0.01% | |
| 361 | Pulse Biosciences Inc. | 0.01% | |
| 362 | Sage Therapeutics Inc. | 0% | |
| 363 | Fate Therapeutics Inc. | 0% | |
| 364 | FibroGen Inc. | 0% | |
| 365 | Cassava Sciences Inc. | 0% | |
| 366 | Nevro Corp. | 0% | |
| 367 | ModivCare Inc. | 0% | |
| 368 | Zentalis Pharmaceuticals Inc. | 0% | |
| 369 | Seres Therapeutics Inc. | 0% | |
| 370 | Enanta Pharmaceuticals Inc. | 0% | |
| 371 | Editas Medicine Inc. | 0% | |
| 372 | American Well Corp. Class A | 0% | |
| 373 | Cutera Inc. | 0% | |
| 374 | Agenus Inc. | 0% | |
| 375 | 2seventy bio Inc. | 0% | |
| 376 | Multiplan Corp. | 0% | |
| 377 | Ventyx Biosciences Inc. | 0% | |
| 378 | Coherus Biosciences Inc. | 0% | |
| 379 | RAPT Therapeutics Inc. | 0% | |
| 380 | Alector Inc. | 0% | |
| 381 | Heron Therapeutics Inc. | 0% | |
| 382 | Atea Pharmaceuticals Inc. | 0% | |
| 383 | Pulmonx Corp. | 0% | |
| 384 | iTeos Therapeutics Inc. | 0% | |
| 385 | ATAI Life Sciences NV | 0% | |
| 386 | Repare Therapeutics Inc. | 0% | |
| 387 | Tango Therapeutics Inc. | 0% | |
| 388 | ALX Oncology Holdings Inc. | 0% | |
| 389 | MacroGenics Inc. | 0% | |
| 390 | IGM Biosciences Inc. | 0% | |
| 391 | Organogenesis Holdings Inc. Class A | 0% | |
| 392 | Aerovate Therapeutics Inc. | 0% | |
| 393 | HilleVax Inc. | 0% | |
| 394 | Outset Medical Inc. | 0% | |
| 395 | 23andMe Holding Co. Class A | 0% | |
| 396 | Definitive Healthcare Corp. Class A | 0% | |
| 397 | Biomea Fusion Inc. | 0% | |
| 398 | Amylyx Pharmaceuticals Inc. | 0% | |
| 399 | Aldeyra Therapeutics Inc. | 0% | |
| 400 | Lyell Immunopharma Inc. | 0% | |
| 401 | Cabaletta Bio Inc. | 0% | |
| 402 | Prime Medicine Inc. | 0% | |
| 403 | ACELYRIN Inc. | 0% | |
| 404 | Mural Oncology plc | 0% | |
| 405 | SCILEX HOLDING CO - RESTRICTED LINE | 0% | |
| 406 | 4D Molecular Therapeutics Inc. | 0% | |
| 407 | Korro Bio Inc. | 0% | |
| 408 | Dianthus Therapeutics Inc. | 0% | |
| 409 | Mineralys Therapeutics Inc. | 0% | |
| 410 | Perspective Therapeutics Inc. | 0% | |
| 411 | Lexicon Pharmaceuticals Inc. | 0% | |
| 412 | Rapport Therapeutics Inc. | 0% | |
| 413 | Tyra Biosciences Inc. | 0% | |
| 414 | Applied Therapeutics Inc. | 0% |
Disclaimer
1. The information provided is for reference only and does not constitute any guarantee of profits or specific stock and price point recommendations.
2. The information is not complete; for comprehensive data, please refer to the relevant websites.
3. All stock market data analyses are subject to survivorship bias.
